I've been eyeing this one off, doing some research.
Can someone provide comment on the following two facts:
1. 'Methoxyflurane' by all accounts tastes a bit nasty. Can anything be done to make the taste more appealing? I know this is minor in the scheme of things because when you need pain relief it won't matter the taste- you'll suck on anything to fix the pain. But has the company ever made comment about the taste?
2. MVP do not actually have protection for Methoxyflurane. I see this as a large risk because if the FDA approve the use, other entrants will enter the market. And again- when you're in pain it doesn't matter the brand of whistle so I don't buy the argument about 'brand' strength.
Just a few questions I am throwing up for comment. I see potential here but need to understand why the market is pricing it the way it is currently. Anyone?
I've been eyeing this one off, doing some research. Can someone...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.020(4.44%) |
Mkt cap ! $40.56M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 48.0¢ | 45.0¢ | $23.01K | 48.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11960 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 916 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
46.5¢ |
Change
0.020 ( 5.32 %) |
||||
| Open | High | Low | Volume | ||
| 45.5¢ | 47.0¢ | 45.5¢ | 12587 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MVP (ASX) Chart |